The estimated Net Worth of Yann Mazabraud is at least $3.07 Milión dollars as of 14 April 2024. Mr Mazabraud owns over 10,375 units of Rhythm Pharmaceuticals stock worth over $1,719,440 and over the last 5 years he sold RYTM stock worth over $659,334. In addition, he makes $693,616 as Exec. VP & Head of International at Rhythm Pharmaceuticals.
Mr has made over 7 trades of the Rhythm Pharmaceuticals stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 10,375 units of RYTM stock worth $511,591 on 14 April 2024.
The largest trade he's ever made was selling 16,000 units of Rhythm Pharmaceuticals stock on 19 March 2024 worth over $627,520. On average, Mr trades about 2,701 units every 53 days since 2019. As of 14 April 2024 he still owns at least 34,870 units of Rhythm Pharmaceuticals stock.
You can see the complete history of Mr Mazabraud stock trades at the bottom of the page.
Yann Mazabraud is the Exec. VP & Head of International at Rhythm Pharmaceuticals.
As the Exec. VP & Head of International of Rhythm Pharmaceuticals, the total compensation of Mr Mazabraud at Rhythm Pharmaceuticals is $693,616. There are 2 executives at Rhythm Pharmaceuticals getting paid more, with Hunter Smith having the highest compensation of $1,922,850.
Mr Mazabraud is 48, he's been the Exec. VP & Head of International of Rhythm Pharmaceuticals since . There are 12 older and 5 younger executives at Rhythm Pharmaceuticals. The oldest executive at Rhythm Pharmaceuticals Inc. is Dr. David P. Meeker M.D., 67, who is the Chairman, Pres & CEO.
Yann's mailing address filed with the SEC is 222 BERKELEY STREET, 12TH FLOOR, , BOSTON, MA, 02116.
Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over $83,445,563 worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth $106,961,700 . The most active insiders traders include Forest Baskett, Scott D Sandell a Peter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of $3,358,405. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth $77,963.
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include: